SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-21-002104
Filing Date
2021-05-18
Accepted
2021-05-18 16:25:55
Documents
40
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q/A FOR XBRL vinings_10qa-xbrl.htm 10-Q/A 22674
  Complete submission text file 0001683168-21-002104.txt   1314619

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE ndyn-20210331.xml EX-101.INS 147386
3 XBRL SCHEMA FILE ndyn-20210331.xsd EX-101.SCH 19057
4 XBRL CALCULATION FILE ndyn-20210331_cal.xml EX-101.CAL 41118
5 XBRL DEFINITION FILE ndyn-20210331_def.xml EX-101.DEF 59763
6 XBRL LABEL FILE ndyn-20210331_lab.xml EX-101.LAB 141260
7 XBRL PRESENTATION FILE ndyn-20210331_pre.xml EX-101.PRE 118409
Mailing Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090 724-934-6467
VININGS HOLDINGS, INC. (Filer) CIK: 0001819663 (see all company filings)

IRS No.: 843998117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-56194 | Film No.: 21936318
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences